Search
Olfactory Transduction OR5A1
smpdb.ca/view/SMP0713868PhysiologicalThis ion flow depolarizes the membrane and, if threshold is reached, triggers an action potential. … Notably, OR2A4 is part of the OR2A subfamily, which includes receptors with overlapping ligand specificity and broad responsiveness to terpenoid and aromatic alcohols.
Enzymes: Calcium-activated chloride channel regulator 1Olfactory Transduction OR1E3
smpdb.ca/view/SMP0713869PhysiologicalThe OR1E3 receptor has been shown to respond to floral and fruity odorants, particularly citronellol and related alcohols with rose-like or citrus notes. … When odorant molecules enter the nasal cavity and dissolve in the mucus layer, certain ligands selectively bind to the OR1E3 receptor.
Enzymes: Calcium-activated chloride channel regulator 1Olfactory Transduction OR1C1
smpdb.ca/view/SMP0713870PhysiologicalOnce the depolarization reaches threshold, an action potential is generated and transmitted along the olfactory nerve to the olfactory bulb. … When odorant molecules enter the nasal cavity and dissolve in the mucus layer, specific ligands bind to the OR1C1 receptor.
Enzymes: Calcium-activated chloride channel regulator 1Olfactory Transduction OR1L3
smpdb.ca/view/SMP0713871PhysiologicalThe OR1L3 receptor has been shown to respond to several floral and aromatic compounds, including helional, cinnamaldehyde, and citronellol. … Variations in OR1L3 gene expression or sequence among individuals may influence sensitivity and perception of these types of odors.
Enzymes: Calcium-activated chloride channel regulator 1Capecitabine Action Pathway (New)
smpdb.ca/view/SMP0125031Drug actionCapecitabine is a prodrug that is selectively tumour-activated to its cytotoxic moiety, fluorouracil, by thymidine phosphorylase, an enzyme found in higher concentrations in many tumors compared to normal … Fluorouracil is further metabolized to two active metabolites, 5-fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP), within normal and tumour cells.
Enzymes: Soluble calcium-activated nucleotidase 1Congenital Disorder of Glycosylation CDG-IId
smpdb.ca/view/SMP0000579Diseaseof oligosaccharides and their transfer. … This protein is responsible for the conversion of D-glucose and uridine diphosphategalactose to alpha-lactose and uridine 5’-diphosphate.
Enzymes: Soluble calcium-activated nucleotidase 1TGF beta Signaling
smpdb.ca/view/SMP0524572SignalingJNK then activates ATF-2 and Jun, important transcription factors. Moreover, MKNK1 also activates Proto-oncogene c-Fos, a key transcription factor involved in cellular responses. … The Akt complex further activates Serine/threonine-protein kinase mTOR, a key regulator of cell growth and metabolism. mTOR then activates Ribosomal protein S6 kinase beta-1, involved in protein synthesis
Drugs: Magnesium cationEnzymes: Mitogen-activated protein kinase 8, Mitogen-activated protein kinase 9Lactose Synthesis
smpdb.ca/view/SMP0000444MetabolicUDP-galactose is then transported into the Golgi by the UDP galactose translocator, an antiporter which uses facilitated transport to move UDP galactose into the Golgi and exports UMP. … Once inside the Golgi, the UDP galactose and glucose (which moves into the golgi via the GLUT-1 transporter) become substrates for the lactose synthase enzyme complex, comprised of the enzymatic subunit
Enzymes: Soluble calcium-activated nucleotidase 1Erlotinib Action Pathway (New)
smpdb.ca/view/SMP0123148Drug actionErlotinib is a drug that is used to treat several types of cancers and prevent the spread of tumors. … It reversibly binds to the intracellular tyrosine kinase ATP binding region of the epidermal growth factor receptor and acts as an inhibitor to prevent ATP from binding to the receptor at its site.
Enzymes: Mitogen-activated protein kinase 1, Mitogen-activated protein kinase kinase kinase 2GLUT-1 Deficiency Syndrome
smpdb.ca/view/SMP0000580DiseaseThis disorder is characterized by dissipation of D-glucose in both Golgi apparatus and cell cytoplasm. Symptoms of the disorder include developmental delays of mental and motor. … GLUT1 deficiency syndrome, also called GLUT1-DS or De Vivo disease, is an autosomal dominant disorder and caused by a defective solute carrier family 2, facilitated glucose transporter member 1.
Enzymes: Soluble calcium-activated nucleotidase 1